Investing.com - Patterson reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Patterson announced earnings per share of $0.58 on revenue of $1.65B. Analysts polled by Investing.com anticipated EPS of $0.5038 on revenue of $1.58B.
Patterson shares are up 6% from the beginning of the year, still down 15.52% from its 52 week high of $37.25 set on June 17. They are under-performing the Nasdaq which is up 20.56% from the start of the year.
Patterson follows other major Healthcare sector earnings this month
Patterson's report follows an earnings beat by Pfizer on November 2, who reported EPS of $1.34 on revenue of $24.09B, compared to forecasts EPS of $1.08 on revenue of $22.58B.
Novo Nordisk ADR had beat expectations on November 3 with third quarter EPS of $0.8209 on revenue of $5.55B, compared to forecast for EPS of $0.7768 on revenue of $5.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar